微创肝切除在高龄患者中的围手术期并发症与死亡率分析
结果显示高龄组术前合并症和ASA评分更高,但术后严重并发症和30天、90天死亡率无显著增加,住院时间延长。
要点
- 高龄(≥70岁)患者微创肝切除术后严重并发症和死亡率未显著增加
- ≥80岁患者并发症均为轻微,但住院时间较长
- 术前合并症和ASA评分较高不构成微创肝切除的绝对禁忌
核心结论
- 尽管术前合并症和ASA评分更高,≥70岁患者微创肝切除术后发病率无显著增加。
主要发现
- B组和C组总体术后并发症发生率分别为12.9%和9.3%,高于A组的6.5%。
- C组并发症均为轻微;B组Clavien-Dindo III-IV级并发症发生率6.8%,A组为2.7%(p=0.43)。
- B组和C组住院时间分别为3.6天和3.5天,长于A组的2.5天(p=0.0012)。
- 三组30天和90天死亡率无显著差异。
关键数值与推荐
- B组和C组MELD评分较高(p=0.047),ASA评分较高(p=0.001)。
- 手术时间(170、157、152分钟;p=0.64)和估计出血量(145、130、145 ml;p=0.95)三组间无统计学差异。
临床怎么用
- 对于≥70岁患者,微创肝切除可考虑作为治疗选择,但需注意术前合并症评估和术后住院时间可能延长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As minimally invasive technique becomes more popular, an increasing number of elderly patients were considered for minimally invasive liver resection (MILR). Limited physiologic reserve remains a major concern, which frequently leads surgeons to recommend nonresectional alternatives. We sought to evaluate complications and outcomes of elderly patients undergoing MILR. METHODS: Eight hundred and thirty-one patients who underwent MILR were classified into groups A, B, and C based on age [(< 70, n = 629), (70-79, n = 148), (≥ 80, n = 54) years old, respectively]. RESULTS: Gender distribution, BMI, and cirrhotic status were comparable among all groups. Groups B and C had higher MELD (p = 0.047) and ASA (p = 0.001) scores. Operative time (170, 157, 152 min; p = 0.64) and estimated blood loss (145, 130, 145 ml; p = 0.95) were statistically equal. Overall postoperative complications were greater in groups B and C (12.9 and 9.3 vs. 6.5%, respectively). Complications in group C were all minor. Clavien-Dindo grade III-IV complications were higher in group B when compared to group A (6.8 vs. 2.7%, p = 0.43). There was no significant difference in cardiopulmonary complications, thromboembolic events, ICU admissions, and transfusion rates seen in groups B and C when compared to group A. Duration of hospital stay was statistically longer in groups B and C (3.6, 3.5 vs. 2.5 days, p = 0.0012). 30- and 90-day mortality rates were comparable among the groups, irrespective of age. CONCLUSIONS: In spite of greater preoperative comorbidities and ASA score, there was no significant increase in postoperative morbidity after minimally invasive liver resection in patients ≥ 70 years of age.
引用
- Sucandy I, Cheek S, Tsung A, et al. Minimally invasive liver resection for primary and metastatic liver tumors: influence of age on perioperative complications and mortality. Surg Endosc. 2017. PMID: 29046959. doi:10.1007/s00464-017-5880-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。